- News and Events
- Professor Mokbel interviewed for Breast Cancer Awareness Week 2014
- Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine
- Towards optimal management of the axilla in the context of a positive sentinel node biopsy in early breast cancer
- Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells
- An Overview of the Clinical Implications of PIP Breast Implants
HCA International commits to provide full support to all PIP breast implant patients
For general enquiries regarding PIP Implants, please call the Helpline on 020 7079 4399
London - 7th January 2012: Last Friday the MHRA advised that they found no evidence to support routine removal of PIP breast implants and they recommended that any patients who were concerned about their implant should seek clinical advice from their consultant surgeon.
HCA International's leadership supports the MHRA's position, and has today issued a commitment to any patients that have had PIP breast implant surgery at one of its hospitals, saying that it will provide full support to address their concerns.
HCA is working closely with its consultants and patients to ensure it finds the most appropriate solution for each individual. If any patients require clinical investigation or further surgical support, including the removal of the PIP implant due to clinical need, HCA will meet the cost incurred.
Michael Neeb, President and Chief Executive, HCA International, comments "recognise that there is a high level of concern amongst patients who have received PIP implants and we are determined to do everything in our power to address these concerns. HCA has built its name providing clinical services of the highest quality to its patients and we have a duty of care to all of them."
"The safety and well-being of HCA patients remains our highest priority."